Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Salento | OTHER |
| Istituto Europeo di Oncologia | OTHER |
| University of Milan | OTHER |
| University of Lisbon |
Not provided
Not provided
Not provided
In this clinical trial, the aim is to determine if regular screening with pooled saliva tests (Lolli-Method) is useful to support school opening and to reduce clusters and attack rates in schools, compared with the standard of care (SoC) regular surveillance based on symptoms and contact tracing by public health departments.
In this clinical trial, it will be determined if regular screening with pooled saliva tests (Lolli-Method) is useful to support school opening and to reduce clusters and attack rates in schools, compared with the standard of care (SoC) regular surveillance based on symptoms and contact tracing by public health departments. A multicenter cluster randomised interventional study will be set-up to evaluate the efficacy and applicability of the Lolli-Methode. The study will enrol 440 classes (around 8800 students, teachers and other personnel) from 2 countries, randomised to Lolli-Methode or SoC. Samples from pools will be regularly collected and tested using PCR-based techniques. Test results will be combined with questionnaires filled in by children, parents and schools teachers and principals, concerning social distancing measures implemented and psychological impact of the preventive measures applied during the pandemic. A thorough data analysis will then be performed to understand the applicability of Lolli-Methode to reduce SARS-COV-2 transmission in schools, including incidence, attack rates and cluster analysis. On the other hand, mobility changes and psychological outcomes will be analysed and compared with variables related to SARS-COV-2 transmission. By the end of this study, it will be identified and characterised the applicability of the Lolli-Methode for SARS-COV-2 surveillance, as well as the impact of pandemic preventive measures on children.
An ancillary observational study will be carried out on a different population of schools to study the prevalence of SARS-COV-2, frequencies and size of clusters and attack rates in schools, compared with those of previous waves; to compare the effectiveness of different preventive measures adopted in different schools; to investigate psychological issues in students and teachers related to the pandemic's containment measures.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LOLLI METHODE | Experimental | regular screening with pooled saliva tests (Lolli-Method) |
|
| STANDARD OF CARE | No Intervention | STANDARD OF CARE |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| LOLLI METHODE | Procedure | WEEKLY SCREENING WITH POOLED SALIVA PCR TEST |
|
| Measure | Description | Time Frame |
|---|---|---|
| Frequencies of clusters | Frequencies of clusters in classrooms in which pooled saliva tests (Lolli-Method) are performed in association with standard contact-tracing protocols, compared with classrooms in which SoC protocols are applied. | up to 18 months |
| Number of participating classes | Number of classes and of students in the classes that accept to participate in the Lolli-Methode study, if asked, during time | up to 18 months |
| Measure | Description | Time Frame |
|---|---|---|
| Transmission/prevalence of SARS-COV-2 in schools by variants | Transmission/prevalence of SARS-COV-2 in schools by variants, by assessing the proportion of students/staff with positive SARS-COV-2 test identified by pooled saliva tests (Lolli-Method) | up to 18 months |
| Psychological status of children |
Not provided
Inclusion Criteria:
Exclusion Criteria:
In case of unknown respiratory infection, no presence of symptoms for at least 48 hours. In case of confirmed SARS-COV-2 infection: inclusion at the earliest 21 days from PCR-positive diagnosis after the onset of potential symptoms and no presence of symptoms for at least 48 hours (according to Standard of Care).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| FRANCESCA INCARDONA | EURESISTE NETWORK GEIE | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| DISTEBA, Università del Salento | Lecce | Apulia | 73100 | Italy | ||
| IEO Istituto Europeo di Oncologia Research Hospital and Treatment Centre |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33880483 | Background | Ozer EA, Simons LM, Adewumi OM, Fowotade AA, Omoruyi EC, Adeniji JA, Dean TJ, Zayas J, Bhimalli PP, Ash MK, Godzik A, Schneider JR, Mamede JI, Taiwo BO, Hultquist JF, Lorenzo-Redondo R. Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in Nigeria. medRxiv [Preprint]. 2021 Jul 2:2021.04.09.21255206. doi: 10.1101/2021.04.09.21255206. | |
| 32853546 |
| Label | URL |
|---|---|
| Otte im Kampe et al, Surveillance of COVID-19 school outbreaks, Germany, March to August 2020, Eveline Otte im Kampe et al., Eurosurveillance, Sept 2020 | View source |
Not provided
The study is part of a project funded by the European Commission and the project agreement with the Commission affirms that the data and the results will be public
after the Study end no time limit was fixed
request to the study coordinator or to he project partners
Not provided
| OTHER |
| University of Cologne | OTHER |
| Hospital Regional de Alta Especialidad "Dr. Juan Graham Casasus" | OTHER |
The study will enrol 440 classes (around 8800 students, teachers and other personnel) from 2 countries, randomised to Lolli-Methode or SoC. Samples from pools will be regularly collected and tested using PCR-based techniques.
Not provided
Not provided
Not provided
Not provided
Psychological status of children during coronavirus pandemics: negative and positive feeling during confinement, worries and expectations about school resumption as evaluated by questionnaires. |
| up to 18 months |
| Milan |
| Lombardy |
| 20141 |
| Italy |
| Università statale di Milano, Dipartimento di Scienze Biomediche e Cliniche L. Sacco | Milan | Lombardy | 20154 | Italy |
| Hospital Regional de Alta Especialidad Dr. Juan Graham Casasus | Villahermosa | Tabasco | 86126 | Mexico |
| Global Health and Tropical Medicine; Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa (UNL) | Lisbon | Lisbon District | 1349-008 | Portugal |
| Robson F, Khan KS, Le TK, Paris C, Demirbag S, Barfuss P, Rocchi P, Ng WL. Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting. Mol Cell. 2020 Sep 3;79(5):710-727. doi: 10.1016/j.molcel.2020.07.027. Epub 2020 Aug 4. |
| 32979941 | Background | Sekine T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, Gorin JB, Olsson A, Llewellyn-Lacey S, Kamal H, Bogdanovic G, Muschiol S, Wullimann DJ, Kammann T, Emgard J, Parrot T, Folkesson E; Karolinska COVID-19 Study Group; Rooyackers O, Eriksson LI, Henter JI, Sonnerborg A, Allander T, Albert J, Nielsen M, Klingstrom J, Gredmark-Russ S, Bjorkstrom NK, Sandberg JK, Price DA, Ljunggren HG, Aleman S, Buggert M. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19. Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14. |
| 33803400 | Background | Singh J, Samal J, Kumar V, Sharma J, Agrawal U, Ehtesham NZ, Sundar D, Rahman SA, Hira S, Hasnain SE. Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications. Viruses. 2021 Mar 9;13(3):439. doi: 10.3390/v13030439. |
| 36597074 | Derived | Raimondi S, Gandini S, Rubio Quintanares GH, Abecasis A, Lopalco PL, D'Ecclesiis O, Chiocca S, Tomezzoli E, Cutica I, Mazzoni D, Amparo N, Pingarilho M, Carmagnola D, Dellavia C, Zuccotti G, Ronchini C, Bellerba F, Dewald F, Kaiser R, Incardona F; Eucare WP4. European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection. BMC Infect Dis. 2023 Jan 3;23(1):1. doi: 10.1186/s12879-022-07947-6. |